Colgate-Palmolive (NYSE:CL) Receives $105.11 Average Price Target from Brokerages

Shares of Colgate-Palmolive (NYSE:CL - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the twenty-two research firms that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have given a buy rating to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $105.11.

Several research firms have recently weighed in on CL. Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and increased their price objective for the stock from $107.00 to $109.00 in a research report on Monday, September 9th. Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating for the company in a research report on Monday, October 28th. UBS Group upped their target price on Colgate-Palmolive from $119.00 to $122.00 and gave the company a "buy" rating in a research report on Wednesday, September 4th. JPMorgan Chase & Co. lifted their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. Finally, Piper Sandler initiated coverage on Colgate-Palmolive in a report on Tuesday, September 24th. They set an "overweight" rating and a $121.00 price target on the stock.

Colgate-Palmolive Trading Down 0.8 %

NYSE:CL traded down $0.74 during mid-day trading on Wednesday, hitting $92.75. 4,849,038 shares of the company's stock were exchanged, compared to its average volume of 4,389,078. Colgate-Palmolive has a fifty-two week low of $76.96 and a fifty-two week high of $109.30. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The firm has a market capitalization of $75.78 billion, a P/E ratio of 26.58, a PEG ratio of 3.31 and a beta of 0.43. The company has a 50 day simple moving average of $95.31 and a 200-day simple moving average of $98.66.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.16%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.

Insider Transactions at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.34% of the company's stock.

Hedge Funds Weigh In On Colgate-Palmolive

Several hedge funds have recently made changes to their positions in CL. Reston Wealth Management LLC bought a new stake in Colgate-Palmolive during the 3rd quarter valued at approximately $42,000. Capital Performance Advisors LLP bought a new position in Colgate-Palmolive in the third quarter worth $53,000. Prospera Private Wealth LLC bought a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at $64,000. Financial Connections Group Inc. purchased a new stake in shares of Colgate-Palmolive in the 2nd quarter worth about $68,000. Finally, True Wealth Design LLC grew its position in shares of Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company's stock worth $75,000 after buying an additional 672 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.